Real-world Persistence of Initial Targeted Therapy Strategy in Monotherapy versus Combination Therapy in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
16/11/2023
Sánchez-Piedra C, Expósito L, VELA P, Moreno Ramos M, Campos C, Bohorquez C, Calvo J, Plaza Z, Domínguez M, Diaz-Gonzalez J
ACR 2023
Sánchez-Piedra C, Expósito L, VELA P, Moreno Ramos M, Campos C, Bohorquez C, Calvo J, Plaza Z, Domínguez M, Diaz-Gonzalez J. Real-world Persistence of Initial Targeted Therapy Strategy in Monotherapy versus Combination Therapy in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/real-world-persistence-of-initial-targeted-therapy-strategy-in-monotherapy-versus-combination-therapy-in-patients-with-rheumatoid-arthritis-psoriatic-arthritis-and-ankylosing-spondylitis/
https://acrabstracts.org/abstract/real-world-persistence-of-initial-targeted-therapy-strategy-in-monotherapy-versus-combination-therapy-in-patients-with-rheumatoid-arthritis-psoriatic-arthritis-and-ankylosing-spondylitis/